Spark Therapeutics' Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Mark Terry… Source: BioSpace You Might Also Like Organogenesis Names New Chief Commercial Officer And Chief Operating Officer September 18, 2017 5 Biotechs Awaiting FDA Decisions in January 2018 December 27, 2017 CEL-SCI Announces That The NYSE MKT Approves Plan February 26, 2017
